Press Release | Texas Medical Center and Ayasdi Announce Strategic Partnership Placing Knowledge from Data

November 13, 2013

The Texas Medical Center (TMC), one of the largest medical centers in the world with more than 50 medicine-related institutions and more than seven million annual patient visits, has selected Ayasdi to provide the complex data infrastructure fundamental for realizing TMC’s mission-based vision and emerge as a world-leading life sciences center. 

TMC’s partnership with Ayasdi leads to a new collaborative culture with unprecedented sharing of data and resources across its member institutions for solving the most complex challenges in healthcare and life sciences.  The Ayasdi platform will be made available to all TMC member organizations, including TMC’s largest research institutions – Baylor College of Medicine, MD Anderson Cancer Center, Houston Methodist, Rice University and UT Health.

“TMC is entering a new era in our evolution where member institutions are exchanging ideas and sharing insights and resources to accelerate discovery to advance care. Specifically, we’re focused on five areas—health policy, stem-cell research, clinical trials, genomics, and innovation—and data is the key to revolutionizing all of them,” said Dr. Robert C. Robbins, President and Chief Executive Officer of TMC. 

TMC endeavors to create a world-class center for complex data research and operational excellence in medicine and research. Integral to achieving that vision, TMC has committed to break down the barriers to institutional data sharing, and facilitate the creation of data infrastructure, services, and technology for the analysis of complex and heterogeneous data sources.

“Ayasdi offers an innovative technology that demonstrates new relationships in data that might otherwise go unnoticed.  It further enhances our ability to convert complex medical data into actionable knowledge,” said Dr. Paul Klotman, President and Chief Executive Officer at Baylor College of Medicine. 

Dr. Ron DePinho, President and Chief Executive Officer at M.D. Anderson Cancer Center added, “This partnership is yet another example of how we intend to leverage the tremendous assets of TMC to accelerate discovery and transform these discoveries into advancing care to patients.”

Ayasdi’s technology allows interdisciplinary collaboration and analysis of clinical, genomic, and public data, replacing data silos with highways, so that TMC can automatically discover and operationalize once unattainable insights.

“We’re honored to work with a world-class organization like the Texas Medical Center to target some of the most challenging diseases and conditions and to accelerate breakthroughs in healthcare and life sciences,” said Gurjeet Singh, Co-Founder and CEO at Ayasdi.

About Texas Medical Center

Considered one of the largest medical centers in the world, TMC is dedicated to the highest standards of patient care, research, and education. Either not-for-profit or governmental, member institutions include 21 renowned hospitals with seven acute care, six pediatric care, and eight specialty care facilities; three public health organizations; two universities; three medical schools; six nursing programs; two pharmacy schools; a dental school; eight academic and research institutions; and 13 support organizations. First Lady Barbara Bush recognized TMC as "Houston's Gift to the World.”  For more information, visit www.texasmedicalcenter.org.

About Ayasdi

Ayasdi is transforming how the world uses data to solve complex problems. Founded in 2008 after a decade of research at Stanford, DARPA, and NSF, Ayasdi is pioneering a new approach for enterprises to automatically discover and operationalize insights from their data. Ayasdi’s Insight Discovery platform uses Topological Data Analysis (TDA) combined with an ensemble of machine learning techniques to enable data scientists, domain experts, and business people to achieve value from their data without the need to write code, queries, or ask questions. Funded by Khosla Ventures, Institutional Venture Partners, GE Ventures, Citi Ventures, and FLOODGATE, Ayasdi’s customers include General Electric, Citigroup, Merck, Anadarko, U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), the University of California San Francisco (UCSF), and Mount Sinai Hospital. To learn more, visit www.ayasdi.com or follow us @ayasdi.